COVAXIN Phase II/III Clinical Trails in Age Group of 2 to 18 Years to Begin in 10-12 Days:
COVAXIN has been approved by the Drugs Controller General of India (DCGI), for Phase II/III clinical trials in the age group of 2 to 18 years. I have been told that trials will begin in the next 10-12 days: Dr. VK Paul, Member-Health, Niti Aayog #COVID19 pic.twitter.com/T0ITsJsixA
— ANI (@ANI) May 18, 2021
(SocialLY brings you all the latest breaking news, viral trends and information from social media world, including Twitter, Instagram and Youtube. The above post is embeded directly from the user’s social media account and Today News 24 Staff may not have modified or edited the content body. The views and facts appearing in the social media post do not reflect the opinions of Today News 24, also Today News 24 does not assume any responsibility or liability for the same.)
articleid = $(this).attr('data-articleid'); articleupdate = $(this).attr('data-articleupdate'); socially_title = $(this).attr('data-articletitle'); socially_url = $(this).attr('data-newurl'); emoji = $(this).attr('data-emoji');
emoji1 = $(this).prevAll(".socially_article_widget2").attr('data-emoji'); socially_url2 = $(this).prevAll(".socially_article_widget2").attr('data-newurl');
var top = window.pageYOffset; var distance = top - $(this).offset().top; var newhref = socially_url;
var scrollTop = $(window).scrollTop(); var top_of_element1 = jQuery(".socially_article").last().offset().top; //console.log("count: "+scrollTop+" "+top_of_element1); if((scrollTop 3000) && !working && currenthref != socially_url1){ working = true; currenthref = socially_url1; var emoji2 = "COVID-19 Vaccine Update: COVAXIN Phase II/III Clinical Trails in Age Group of 2 to 18 Years to Begin in 10-12 Days | ? Today News 24"; console.log("count1"); var newhref1 = "https://www.todaynews24.top/socially/india/news/covid-19-vaccine-update-covaxin-phase-iiiii-clinical-trails-in-age-group-of-2-to-18-years-to-begin-in-10-12-days-2487860.html"; $('h1:first').text("COVID-19 Vaccine Update: COVAXIN Phase II/III Clinical Trails in Age Group of 2 to 18 Years to Begin in 10-12 Days"); $(document).find("title").text(emoji2) window.history.pushState("","","https://www.todaynews24.top/socially/india/news/covid-19-vaccine-update-covaxin-phase-iiiii-clinical-trails-in-age-group-of-2-to-18-years-to-begin-in-10-12-days-2487860.html"); gtag('config', 'UA-111635423-1', { 'page_path': newhref1.replace("https://"+window.location.hostname+"/", "")}); setTimeout(function(){ working=false; }, 400); return false; }
//console.log("distance "+distance+" && working"+working+" &¤thref:"+currenthref+" && newhref"+newhref+" && socially_url2"+socially_url2+" "+k); if(distance -900 && !working && newhref != socially_url2 && currenthref == newhref && typeof socially_url2 != 'undefined'){ newhref = socially_url2; currenthref = newhref; console.log("change url2"+newhref); working = true;
$('h1:first').text($(this).prevAll(".socially_article_widget2").attr('data-articletitle')); $('meta[property=og\:title]').attr('content', $(this).prevAll(".socially_article_widget2").attr('data-articletitle')); $('meta[property=og\:url]').attr('content', newhref); $(document).find("title").text($(this).prevAll(".socially_article_widget2").attr('data-articletitle')+' | '+emoji1+' Today News 24') window.history.pushState("","",newhref); gtag('config', 'UA-111635423-1', { 'page_path': newhref.replace("https://"+window.location.hostname+"/", "")}); self.COMSCORE && COMSCORE.beacon({ c1: "2", c2: "27040963" });
setTimeout(function(){ working=false; }, 500); return false; }else if (distance -450 && !working && currenthref != newhref) { working = true;
currenthref = newhref; console.log("change url1"+newhref); $('h1:first').text($(this).attr('data-title')); $('meta[property=og\:title]').attr('content', socially_title); $('meta[property=og\:url]').attr('content', newhref); $(document).find("title").text(socially_title +' | '+emoji+' Today News 24') window.history.pushState("","",newhref); //var res = newhref.replace("https://www.todaynews24.top/", ""); gtag('config', 'UA-111635423-1', { 'page_path': newhref.replace("https://"+window.location.hostname+"/", "")}); self.COMSCORE && COMSCORE.beacon({ c1: "2", c2: "27040963" }); setTimeout(function(){ working=false; }, 400); return false; } }); var bottom_of_screen = jQuery(window).scrollTop() + window.innerHeight; var top_of_element = jQuery(".container .article-footer").last().offset().top; if(bottom_of_screen > top_of_element && !visible){ visible = true; k=k+1; if(k==2 && false){ var dm_js = document.createElement('script'); dm_js.src="https://stfe.todaynews24.top/js/dm-ce.min.js?v=1.1"; dm_js.async="async"; document.body.appendChild(dm_js); } $.ajax({ method: "GET", url: "/larajax/live-socially-ajax/", data:{ curr_socially:articleid,curr_date:articleupdate,index:k }, dataType: 'json' }).done(function( data ) { $(".socially_article").append(data.html); $("img.lazyload").lazyload(); window.instgrm.Embeds.process(); var slotName = "div-gpt-ad-1560419575255-"+k; googletag.cmd.push(function() { var slot = googletag.defineSlot('/21682383758/latestly_728x90_btf1', [728, 90], slotName). addService(googletag.pubads()); googletag.display(slotName); googletag.pubads().refresh([slot]); }); googletag.cmd.push(function() { googletag.display('div-gpt-ad-1560419575255-'+k); }); var slotName = "div-gpt-ad-1568807958472-"+k; googletag.cmd.push(function() { var slot = googletag.defineSlot('/21682383758/728x90_Top', [728, 90], slotName). addService(googletag.pubads()); googletag.display(slotName); googletag.pubads().refresh([slot]); }); googletag.cmd.push(function() { googletag.display('div-gpt-ad-1568807958472-'+k); });
loadAPI_Social_js()
var js_fb = document.createElement('script'); js_fb.src="https://connect.facebook.net/en_US/sdk.js#xfbml=1&version=v3.3&appId=224265671451116&autoLogAppEvents=1"; document.body.appendChild(js_fb);
//colombai try{ (function() { var cads = document.createElement("script"); cads.async = true; cads.type = "text/javascript"; cads.src = "https://static.clmbtech.com/ase/80185/3040/c1.js"; var node = document.getElementsByTagName("script")[0]; node.parentNode.insertBefore(cads, node); })(); }catch(e){} }); }else if(bottom_of_screen
//vdo (function(v,d,o,ai){ai=d.createElement('script');ai.defer=true;ai.async=true;ai.src=v.location.protocol+o;d.head.appendChild(ai);})(window, document, '//a.vdo.ai/core/latestly/vdo.ai.js');
//colombai try{ (function() { var cads = document.createElement("script"); cads.async = true; cads.type = "text/javascript"; cads.src = "https://static.clmbtech.com/ase/80185/3040/c1.js"; var node = document.getElementsByTagName("script")[0]; node.parentNode.insertBefore(cads, node); })(); }catch(e){}
} });